|
|
||||||||
Journal of Nuclear Medicine Technology, Vol 27, Issue 1 48-50, Copyright © 1999 by Society of Nuclear Medicine
ARTICLES |
WJ Shih, MT Hackett, V Stipp, K Gross and C Pulmano
Nuclear Medicine Service, VA Medical Center, Lexington, KY 40511-1093, USA.
Gallium-67-citrate and 99mTc-diphosphate bone imaging agents are localized in myositis ossificans, a tumor-like benign soft-tissue mass that makes it impossible to differentiate between malignant tumor and the infection/inflammatory process. We present such a myositis ossificans patient whose bone and 67Ga-citrate imagings showed increased uptake in the left thigh and two foci of the right gluteal region leading to inconclusive results. Technetium-99m-MIBI imaging showed the absence of substantial uptake in these regions. ACT scan confirmed myositis ossificans. The lack of 99mTc-MIBI uptake in myositis ossificans means that 99mTc-MIBI imaging may be useful in the differential diagnosis.
This article has been cited by other articles:
![]() |
J. T. Kim, Y. H. Yoon, W. K. Baek, J. Y. Han, Y. C. Chu, and H.-J. Kim Myositis ossificans of the chest wall simulating malignant neoplasm Ann. Thorac. Surg., November 1, 2000; 70(5): 1718 - 1720. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE JOURNAL OF NUCLEAR MEDICINE | JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY |